ALLR
Price
$1.11
Change
+$0.10 (+9.90%)
Updated
Apr 24, 02:14 PM (EDT)
Capitalization
16.86M
NRXP
Price
$2.05
Change
+$0.07 (+3.54%)
Updated
Apr 24, 02:30 PM (EDT)
Capitalization
32.31M
Ad is loading...

ALLR vs NRXP

Header iconALLR vs NRXP Comparison
Open Charts ALLR vs NRXPBanner chart's image
Allarity Therapeutics
Price$1.11
Change+$0.10 (+9.90%)
Volume$8.2K
Capitalization16.86M
NRX Pharmaceuticals
Price$2.05
Change+$0.07 (+3.54%)
Volume$100
Capitalization32.31M
ALLR vs NRXP Comparison Chart
Loading...
ALLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLR vs. NRXP commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLR is a StrongBuy and NRXP is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (ALLR: $1.01 vs. NRXP: $1.98)
Brand notoriety: ALLR and NRXP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLR: 76% vs. NRXP: 30%
Market capitalization -- ALLR: $16.86M vs. NRXP: $32.31M
ALLR [@Biotechnology] is valued at $16.86M. NRXP’s [@Biotechnology] market capitalization is $32.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLR’s FA Score shows that 1 FA rating(s) are green whileNRXP’s FA Score has 0 green FA rating(s).

  • ALLR’s FA Score: 1 green, 4 red.
  • NRXP’s FA Score: 0 green, 5 red.
According to our system of comparison, ALLR is a better buy in the long-term than NRXP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLR’s TA Score shows that 5 TA indicator(s) are bullish while NRXP’s TA Score has 5 bullish TA indicator(s).

  • ALLR’s TA Score: 5 bullish, 4 bearish.
  • NRXP’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NRXP is a better buy in the short-term than ALLR.

Price Growth

ALLR (@Biotechnology) experienced а +26.71% price change this week, while NRXP (@Biotechnology) price change was +2.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.11%. For the same industry, the average monthly price growth was -6.02%, and the average quarterly price growth was -12.55%.

Reported Earning Dates

ALLR is expected to report earnings on Mar 31, 2025.

NRXP is expected to report earnings on Mar 14, 2025.

Industries' Descriptions

@Biotechnology (+7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRXP($32.3M) has a higher market cap than ALLR($16.9M). NRXP YTD gains are higher at: -10.000 vs. ALLR (-13.675). ALLR has higher annual earnings (EBITDA): -18.26M vs. NRXP (-24.89M). ALLR has more cash in the bank: 18.5M vs. NRXP (1.44M). ALLR has less debt than NRXP: ALLR (1.34M) vs NRXP (6.58M). ALLR (0) and NRXP (0) have equivalent revenues.
ALLRNRXPALLR / NRXP
Capitalization16.9M32.3M52%
EBITDA-18.26M-24.89M73%
Gain YTD-13.675-10.000137%
P/E RatioN/A0.36-
Revenue00-
Total Cash18.5M1.44M1,282%
Total Debt1.34M6.58M20%
FUNDAMENTALS RATINGS
NRXP: Fundamental Ratings
NRXP
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLRNRXP
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
67%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ALLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRNS0.820.06
+8.02%
Barinthus Biotherapeutics plc
KRG21.840.25
+1.16%
Kite Realty Group Trust
FIS79.410.29
+0.37%
Fidelity National Information Services
FNLC24.21-0.19
-0.78%
First Bancorp
ALEX16.64-0.18
-1.07%
Alexander & Baldwin

ALLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLR has been closely correlated with SNPX. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALLR jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLR
1D Price
Change %
ALLR100%
+1.93%
SNPX - ALLR
87%
Closely correlated
+8.28%
AGEN - ALLR
87%
Closely correlated
-0.70%
RNAC - ALLR
86%
Closely correlated
+3.37%
NCNA - ALLR
86%
Closely correlated
+14.09%
NRXP - ALLR
81%
Closely correlated
+3.66%
More

NRXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXP has been closely correlated with RNAC. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXP
1D Price
Change %
NRXP100%
+3.66%
RNAC - NRXP
86%
Closely correlated
+3.37%
NCNA - NRXP
85%
Closely correlated
+14.09%
SNPX - NRXP
84%
Closely correlated
+8.28%
AGEN - NRXP
83%
Closely correlated
-0.70%
ALLR - NRXP
81%
Closely correlated
+1.93%
More